Abstract:Background: Acetylpuerarin (AP), because of its lower water solubility, shows poor absorption that hinders its therapeutic application. Thus, the aim of this study was to prepare nanoemulsions for AP, enhance its oral bioavailability, and thus improve the therapeutic effect.Methods: The nanoemulsions stabilized by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) were prepared by high-pressure homogenization and characterized in terms of particle size, drug loading, morphology, and in vitro drug release. A lipid digestion model was used to predict in vivo drug solubilization in the gastrointestinal environment. The pharmacokinetics of AP formulations were performed in rats; meanwhile, a chylomicron flow-blocking rat model was used to evaluate the lymphatic drug transport. Moreover, the therapeutic effects of AP nanoemulsions on the model of focal cerebral ischemia-reperfusion for brain injury were also assessed.Results: The nanoemulsions with a droplet size of 150 nm were well stabilized by TPGS and showed a high loading capacity for AP. In the digestion model, the distribution of AP in aqueous phase/pellet phase was about 90%/10% for nanoemulsions and 5%/95% for oil solution, indicating that the drug encapsulated in nanoemulsions would present in solubilized form after transportation into the gastrointestinal tract, whereas drug precipitation would occur as the oil solution was orally administered. The area under the curve value of AP nanoemulsions was 5.76 +/- 0.56 mu g hour mL(-1), or was about 2.6 and 1.7 times as great as that of suspension and oil solution, respectively, indicating enhanced drug absorption and thus achieving a better neuroprotection effect on cerebral ischemic reperfusion injury. The values of peak plasma concentration and area under the curve from the blocking model were significantly less than those of the control model, suggesting that the lymphatic transport performed a very important role in absorption enhancement.Conclusion: Enhanced oral bioavailability in nanoemulsions was achieved via the mechanism of the maintenance of drug solubilization in the gastrointestinal tract and the enhancement of lymphatic transport, which resulted in therapeutic improvement of cerebral ischemic reperfusion injury.

Preparation, preliminary pharmacokinetics and brain tissue distribution of Tanshinone IIA and Tetramethylpyrazine composite nanoemulsions.

Preparation, Optimization and Cellular Uptake Study of Tanshinone I Nanoemulsion Modified with Lactoferrin for Brain Drug Delivery.

Preparation and In Vitro and In Vivo Evaluation Of Panax Notoginseng Saponins-loaded Nanoparticles Coated with Trimethyl Chitosan Derivatives

Preparation of Tanshinone IIA Long-Circulating Solid Lipid Nanoparticles and Study of Its Physico-Chemical Properties

Enhanced Oral Absorption and Therapeutic Effect of Acetylpuerarin Based on D-Alpha-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoemulsions

Preparation and transdermal resorption of tanshinone ethosomes in vitro

Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability

Application of a novel multicomponent nanoemulsion to tumor therapy Based on the theory of "unification of drugs and excipients"

Preparation, Characterization and Stability Studies of Tanshinone IIA Micro-Emulsion

Preparation of Water-Soluble Chitosan/poly-Gama-glutamic Acid-Tanshinone IIA Encapsulation Composite and Its in Vitro/in Vivo Drug Release Properties.

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

Preparation of water-soluble chitosan/poly-gama-glutamic acid-tanshinone IIA encapsulation composite and its<i>in vitro</i>/<i>in vivo</i>drug release properties

Therapeutic Effects of Tanshinone IIA and Tetramethylpyrazine Nanoemulsions on Cognitive Impairment and Neuronal Damage in Alzheimer's Disease Rat Models.

Improvement of Bioavailability and Dissolution of Tanshinone IIA by Encapsulating It with Hydroxypropyl-β-Cyclodextrin

Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.

Preparation, characterization and pharmacokinetic studies of total paeony glycoside nanocrystals

Preparation and quality evaluation of tanshinone ⅡA self nano emulsifying drug delivery system

Therapeutic effects of Tanshinone IIA and Tetramethylpyrazine nanoemulsions on cognitive impairment and neuronal damage in Alzheimer’s disease rat models

TPGS-g-PLGA/Pluronic F68 Mixed Micelles for Tanshinone IIA Delivery in Cancer Therapy.

Large Volume Direct Injection Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Comparative Pharmacokinetic Study Between Single And Combinatory Uses Of Carthamus Tinctorius Extract And Notoginseng Total Saponins

PEG-poly(amino acid)s-encapsulated tanshinone IIA as potential therapeutics for the treatment of hepatoma.